Background:
@EN the goal of this study was to demonstrate the effect of esmolol to prevent reflex tachycardia occurred during sodium nitroprussde(SNP) induced hypotension.
@ES Methods:
@EN Thirty patients were randomly assigned to the SNP group(n=15) received continuous infusion of SNP at 2.72±0.56 mcg/kg/min or combined SNP and esmolol(SNP-ESM) group(n=15) received combined continuous infusion of SNP at 1.54±0.34 mcg/kg/min
and
esmolol at 200mg/kg/min for 1 hour to maintain a 20~25% reduction of mean arterial pressure(MAP) from baseline. Heart rate(HR) and MAP were measured at baseline, during hypotensive period(5, 10, 20, 30, 60 min) and after hypotensive period(70,
80,
90, 1
20 min).
@ES Results:
@EN SNP-induced hypotension resulted in significant(P<0.001) increases in heart rate during hypotensive period and MAP after the end of SNP infusion. However, infusion of SNP-FSM resulted in significant(p<0.05) reduction in heart rate and SNP
requirement, during hypotensive period, and rebound hypertension was not observed after the end of induced hypotension.
@ES Conclusion:
@EN SNP-ESM infusion is a safe and effective pharmacologic means and provides several advantages over single SNP that include reduction in SNP requirement, no reflex tachycardia during induced hypotension and no rebound hypertension following
hypotensive period.
|